David Meyronet

Affiliations: 
Universite Lyon 1, Villeurbanne, Auvergne-Rhône-Alpes, France 
Area:
Semaphorin, CRMP, MAPK, Cancer, Marker, Cell migration, Apoptosis
Google:
"David Meyronet"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Nicole Thomasset grad student 2009 Universite Lyon 1
 (Implication des collapsin response mediator protein (crmp) et des voies de signalisation des semaphorines en pathologie tumorale)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

D'Angelo F, Ceccarelli M, Tala, et al. (2018) The molecular landscape of glioma in patients with Neurofibromatosis 1. Nature Medicine
Royet A, Broutier L, Coissieux MM, et al. (2017) Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4. Oncotarget. 8: 23750-23759
Denicolaï E, Tabouret E, Colin C, et al. (2016) Molecular heterogeneity of glioblastomas: does location matter? Oncotarget. 7: 902-13
Frappaz D, Chinot OL, Meyronet D, et al. (2016) MEVITEM: A European, randomized, open-label Phase I/II of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent/ refractory medulloblastoma presenting an activation of the Sonic Hedgehog pathway. Journal of Clinical Oncology. 34
Moutal A, Honnorat J, Massoma P, et al. (2015) CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling. Cancer Research. 75: 3519-28
Meyronet D, Dorey A, Massoma P, et al. (2015) The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 975-91
Rivera LB, Meyronet D, Hervieu V, et al. (2015) Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy. Cell Reports. 11: 577-91
Brot S, Malleval C, Benetollo C, et al. (2013) Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation. Experimental Cell Research. 319: 588-99
Meyronet D, Massoma P, Thivolet F, et al. (2008) Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma. The American Journal of Surgical Pathology. 32: 1699-708
Kusy S, Nasarre P, Chan D, et al. (2005) Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. Neoplasia (New York, N.Y.). 7: 457-65
See more...